[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

DNA Sequencing Market Report: Trends, Forecast and Competitive Analysis

May 2024 | 150 pages | ID: D5324D43E3C4EN
Lucintel

US$ 4,850.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Get it in 2 to 4 weeks by ordering today

The future of the global DNA sequencing market looks promising with opportunities in biomarkers & cancer, diagnostics, reproductive health, personalized medicine, and forensics applications. The global DNA sequencing market is expected to grow with a CAGR of 17%-19% from 2020 to 2025. The major drivers for this market are growing demand for personalized genomics, increasing cancer research activities, and increasing demand for fast and easy clinical diagnosis.

A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global DNA sequencing market report, please download the report brochure.

In this market, instruments is the fastest growing product of DNA sequncing, whereas biomarker & cancer is the largest application. Growth in various segments of the DNA sequencing market are given below:

The study includes trends and forecast for the global DNA sequencing market by product, technology, application, end user, and region as follows:

By Product [Value ($ Million) shipment analysis for 2014 – 2025]:

ConsumablesInstrumentsServices

By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:

Sequencing by SynthesisIon Semiconductor SequencingSequencing by LigationPyrosequencingSingle Molecule Real-Time SequencingChain Termination SequencingNanopore Sequencing

By Application [Value ($ Million) shipment analysis for 2014 – 2025]:

Biomarkers and CancerDiagnosticsReproductive HealthPersonalized MedicineForensicsOthers

By End User [Value ($ Million) shipment analysis for 2014 – 2025]:

Academic & Government Research InstitutesPharmaceutical CompaniesBiotechnology CompaniesHospitals & Clinics

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:

North AmericaUnited StatesCanada MexicoEuropeUnited KingdomGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil

Some of the DNA sequencing companies profiled in this report include Abbott Laboratories, Agilent Technologies, Danaher, Roche, Illumina, LI-COR Biosciences, Pacific Biosciences of California, Siemens, PerkinElmer, and Thermo Fisher Scientific.

Lucintel forecasts that instruments will remain the fastest growing segment over the forecast period due to recent innovations in DNA sequencing instruments.

Within this market, biomarkers and cancer will remain the largest segment by application over the forecast period due to increasing usage of cancer biomarkers in drug discovery & development and rising aging population.

North America will remain the largest region over the forecast period due to increasing technological advancements in sequencing and availability of skilled manpower in the region.

Features of the Global DNA Sequencing Market

Market Size Estimates: Global DNA sequencing market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global DNA sequencing market size by various segments, such as product, technology, application, and end user, in terms of value.Regional Analysis: Global DNA sequencing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different products, technologies, applications, end users, and regions for the global DNA sequencing market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global DNA sequencing market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

This report answers following key questions

Q.1 What are some of the most promising potential, high-growth opportunities for the global DNA sequencing market by product (consumables, instruments, and services), technology (sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real-time sequencing, chain termination sequencing, and nanopore sequencing), application (biomarkers and cancer, diagnostics, reproductive health, personalized medicine, forensics, and others), end user (academic & government research institutes, pharmaceutical companies, biotechnology companies, and hospitals & clinics), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global DNA sequencing market?
Q.5 What are the business risks and threats to the global DNA sequencing market?
Q.6 What are the emerging trends in this DNA sequencing market and the reasons behind them?
Q.7 What are some changing demands of customers in the DNA sequencing market?
Q.8 What are the new developments in the DNA sequencing market? Which companies are leading these developments?
Q.9 Who are the major players in the DNA sequencing market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in the DNA sequencing market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global DNA sequencing market?

Report Scope

Key Features Description

Base Year for Estimation 2019

Trend Period

(Actual Estimates) 2014-2019

Forecast Period 2020-2025

Pages More than 150

Market Representation / Units Revenue in US $ Million

Report Coverage Market Trends & Forecast, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling

Market Segments Product (Consumables, Instruments, and Services), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics)

Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)

Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY

2. MARKET BACKGROUND AND CLASSIFICATIONS

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T  2025

3.1: Macroeconomic Trends and Forecast
3.2: Global DNA Sequencing Market Trends and Forecast
3.3: Global DNA Sequencing Market by Product
  3.3.1: Consumables
  3.3.2: Instruments
  3.3.3: Services
3.4: Global DNA Sequencing Market by Technology
  3.4.1: Sequencing by Synthesis
  3.4.2: Ion Semiconductor Sequencing
  3.4.3: Sequencing by Ligation
  3.4.4: Pyrosequencing
  3.4.5: Single Molecule Real-time Sequencing
  3.4.6: Chain Termination Sequencing
  3.4.7: Nanopore Sequencing
3.5: Global DNA Sequencing Market by Application
  3.5.1: Biomarkers and Cancer
  3.5.2: Diagnostics
  3.5.3: Reproductive Health
  3.5.4: Personalized Medicine
  3.5.5: Forensics
  3.5.6: Others
3.6: Global DNA Sequencing Market by End User
  3.6.1: Academic & Government Research Institutes
  3.6.2: Pharmaceutical Companies
  3.6.3: Biotechnology Companies
  3.6.4: Biotechnology Companies

4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION

4.1: Global DNA Sequencing Market by Region
4.2: North American DNA Sequencing Market
  4.2.1: Market by Product: Consumables, Instruments, and Services
  4.2.2: Market by Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing
  4.2.3: Market by Application: Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others
  4.2.4: Market by End User: Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics
  4.2.5: The United States DNA Sequencing Market
  4.2.6: The Canadian DNA Sequencing Market
  4.2.7: The Mexican DNA Sequencing Market
4.3: European DNA Sequencing Market
  4.3.1: Market by Product: Consumables, Instruments, and Services
  4.3.2: Market by Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-Time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing
  4.3.3: Market by Application: Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others
  4.3.4: Market by End User: Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics
  4.3.5: The DNA Sequencing Market of the United Kingdom
  4.3.6: The German DNA Sequencing Market
  4.3.7: The French DNA Sequencing Market
4.4: APAC DNA Sequencing Market
  4.4.1: Market by Product: Consumables, Instruments, and Services
  4.4.2: Market by Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-Time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing
  4.4.3: Market by Application: Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others
  4.4.4: Market by End User: Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics
  4.4.5: The Chinese DNA Sequencing Market
  4.4.6: The Indian DNA Sequencing Market
  4.4.7: The Japanese DNA Sequencing Market
4.5: ROW DNA Sequencing Market
  4.5.1: Market by Product: Consumables, Instruments, and Services
  4.5.2: Market by Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-Time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing
  4.5.3: Market by Application: Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others
  4.5.4: Market by End User: Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics
  4.5.5: Brazilian DNA Sequencing Market

5. COMPETITOR ANALYSIS

5.1: Market Share Analysis
5.2: Product Portfoli  Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis

6. COST STRUCTURE ANALYSIS

6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin

7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS

7.1: Growth Opportunity Analysis
  7.1.1: Growth Opportunities for the Global DNA Sequencing Market by Product
  7.1.2: Growth Opportunities for the Global DNA Sequencing Market by Technology
  7.1.3: Growth Opportunities for the Global DNA Sequencing Market by Application
  7.1.4: Growth Opportunities for the Global DNA Sequencing Market by End User
  7.1.5: Growth Opportunities for the Global DNA Sequencing Market by Region
7.2: Emerging Trends in the Global DNA Sequencing Market
7.3: Strategic Analysis
  7.3.1: New Product Development
  7.3.2: Capacity Expansion of the Global DNA Sequencing Market
  7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global DNA Sequencing Market
  7.3.4: Certification and Licensing

8. COMPANY PROFILES OF LEADING PLAYERS

8.1: Abbott Laboratories
8.2: Agilent Technologies, Inc.
8.3: Danaher Corporation
8.4: F. Hoffmann-La Roche Ltd.
8.5: Illumina, Inc.
8.6: LI-COR Biosciences, Inc.
8.7: Pacific Biosciences of California, Inc.
8.8: SIEMENS AG
8.9: PerkinElmer Inc.
8.10: Therm  Fisher Scientific, Inc.


More Publications